Summary
The Trump administration's Centers for Medicare & Medicaid Services (CMS) announced that Medicaid and CHIP will cease funding for child sex-change hormones and surgeries. CMS Administrator Dr. Mehmet Oz stated the decision aligns with protecting children from experimental and life-altering procedures lacking sufficient evidence of clinical benefit.